Novartis loses patent battle in SC over cancer drug

As per the new article report, a landmark verdict by the Supreme Court on today rejected a plea by Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India, thereby paving way for the continued production of the drug’s generic version by Indian companies. The said article can be accessed here.